Sigma receptors: recent advances and new clinical potentials
- 1 March 2000
- journal article
- review article
- Published by Elsevier in Pharmaceutica Acta Helvetiae
- Vol. 74 (2-3) , 211-218
- https://doi.org/10.1016/s0031-6865(99)00034-5
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Characterization of p53 oligomerization domain mutations isolated from Li–Fraumeni and Li–Fraumeni like family membersOncogene, 1998
- Synthesis, In Vitro Binding, and Tissue Distribution of Radioiodinated 2-[125I]N-(N-Benzylpiperidin-4-yl)-2-Iodo Benzamide, 2-[125I]BP: A Potential σ Receptor Marker for Human Prostate TumorsNuclear Medicine and Biology, 1998
- Apoptosis: an overviewBritish Medical Bulletin, 1997
- Rat liver and kidney contain high densities of σ1 and σ2 receptors: characterization by ligand binding and photoaffinity labelingEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- σ Receptor-active neuroleptics are cytotoxic to C6 glioma cells in cultureEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- JO 1784, a potent and selective ligand for rat and mouse brain σ-sitesJournal of Pharmacy and Pharmacology, 1990
- Haloperidol-sensitive (+)[3H]SKF-10,047 binding sites (σ sites) exhibit a unique distribution in rat brain subcellular fractionsEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- Classification and nomenclature of phencyclidine and sigma receptor sitesTrends in Neurosciences, 1987
- Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brainLife Sciences, 1986
- Endogenous ligands for sigma opioid receptors in the brain (“sigmaphin”): Evidence from binding assaysLife Sciences, 1986